7-Day Holter Monitoring Outperformed Shorter Recording Windows in Children With Suspected Arrhythmia
Ambulatory rhythm monitoring in children has long been constrained by a familiar problem: symptoms come and go, while a brief recording window often misses the event entirely. In this single-center cohort from National Taiwan University Children’s Hospital, a 7-day Holter strategy identified more clinically important arrhythmias than either the first 24 hours of recording or a 7-day event-recorder approach. The gap was most apparent for major arrhythmias, the category that included tachyarrhythmia and bradyarrhythmia and carried the clearest management implications.
The study included 435 children younger than 18 years, with a mean age of 12.3 years and a near-even sex distribution. Over the surveillance period, the mean analyzable monitoring time reached 4.9 days, giving investigators a meaningful view of how extended rhythm capture performs in real pediatric practice rather than in a narrow laboratory setting. Patients were followed for 1 year, and the final arrhythmia diagnosis served as the reference standard. Diagnostic yield was paired with a second, more bedside-relevant endpoint: whether monitoring findings changed clinical management.
A brief rhythm strip can be reassuring, but it can also be falsely silent.
Why Longer Continuous Recording Matters in Pediatric Rhythm Assessment
The diagnostic logic is straightforward. Pediatric arrhythmias are often intermittent, and symptoms may be sporadic, nonspecific, or difficult for younger children to describe. A continuous monitor that spans several days improves the odds of catching transient conduction abnormalities, paroxysmal tachyarrhythmias, or episodic bradyarrhythmias that simply do not recur during the first day of testing. An event recorder depends on the patient or family to trigger capture during symptoms, which can miss asymptomatic events or episodes too brief to prompt activation.
In this cohort, 411 children activated the event recorder at least once, and 10.7% had symptom-correlated arrhythmias. Even with that level of engagement, symptom-triggered capture remained limited as a sole diagnostic strategy. The 7-day Holter approach detected major arrhythmias in 6.2% of children, compared with 2.3% with the 24-hour Holter and 2.3% with 7-day event recordings. The rate difference between the longer continuous monitor and the shorter approaches was 1.9% to 6.0%, with a statistically significant difference reported.
Those numbers matter because the label “major” is not just administrative. Tachyarrhythmias and bradyarrhythmias are the findings most likely to prompt medication adjustment, electrophysiology referral, closer follow-up, or reassurance after a negative workup. A monitoring strategy that misses them leaves clinicians deciding between under-treatment and unnecessary escalation based on incomplete information. Continuous recording for a full week gives the heart more chances to reveal unstable rhythm behavior during ordinary school days, sleep, exercise, and symptom fluctuation.
Symptom Correlation Was Helpful, But Continuous Capture Found More
The event recorder did recover symptom-linked arrhythmias in a subset of children, and that remains clinically useful when symptoms are frequent and clearly perceived. Palpitations, dizziness, or episodic discomfort can align with rhythm disturbances and help separate arrhythmic symptoms from anxiety, musculoskeletal pain, or benign ectopy. Yet symptom correlation alone cannot solve the broader diagnostic problem in pediatric cardiology, because not every clinically relevant arrhythmia is felt when it occurs.
In practice, the most important diagnosis may be the one the child never notices. Silent tachyarrhythmias, intermittent AV conduction problems, and brief bradyarrhythmic episodes can hide behind normal daytime vitals and a normal in-office electrocardiogram. Continuous ambulatory monitoring extends the observation window enough to expose those episodes before they are lost to timing.
The study’s 1-year follow-up design also strengthens the practical value of the findings. Using the final arrhythmia diagnosis as the reference standard provided a more durable benchmark than a single encounter could offer. In pediatric patients, where symptom reports can evolve over time and family observation may change, that longer horizon helps anchor interpretation in actual clinical course rather than in a narrow snapshot.
Clinical Management Changed When Monitoring Was More Informative
The secondary endpoint addressed a question that often drives ordering decisions in the clinic: does the monitor change what physicians do next? The study defined change in clinical management as an outcome attributable to monitoring findings, and that framing places the technology in the context that matters most to families and clinicians. A monitor is only as useful as its ability to reduce uncertainty, direct therapy, or prevent missed disease.
The extended continuous approach appears to have delivered more actionable information because it detected more major arrhythmias than either comparator. In pediatric cardiology, those findings can alter follow-up frequency, trigger medication decisions, or justify additional testing. Even when the ultimate decision is reassurance, reassurance is more defensible when it rests on a longer and more complete rhythm record.
The analyzable duration also deserves attention. A mean of 4.9 days of interpretable data indicates that extended monitoring remained feasible in this outpatient and inpatient population. Feasibility matters because a more sensitive monitor has little clinical value if children cannot tolerate it or families cannot use it consistently. Here, the longer protocol generated enough usable recording to make the comparison clinically meaningful.
What This Means for Pediatric Rhythm Workups
This cohort supports a more deliberate use of extended continuous ambulatory monitoring when pediatric arrhythmia suspicion persists after shorter testing. A 24-hour Holter may still be adequate for frequent symptoms, but it is a blunt tool for intermittent disease. The 7-day continuous method sharpened detection of major arrhythmias without relying on perfect symptom timing, and that is a practical advantage in children whose episodes may be brief, unpredictable, or difficult to describe.
The findings also challenge the assumption that a family-triggered recording strategy is always enough once symptoms are under observation. Symptom activation helped in a subset, but it did not match the yield of the longer continuous device for major rhythm abnormalities. For pediatric clinicians, the message is not that one monitor replaces every other monitor. It is that the rhythm problem should dictate the recording strategy, and intermittent disease often demands longer observation than a single day can provide.
The study remains single-center, and the population came from one children’s hospital in Taiwan, so broader generalization still needs confirmation across other pediatric settings and referral patterns. Even so, the direction of the data is hard to ignore: when arrhythmia is intermittent, duration improves detection, and detection can change care. The remaining question is how best to match monitor type to symptom frequency, age, and clinical suspicion without overtesting children who may only need reassurance after a standard workup.